Cargando…
Gynecomastia caused by ethionamide
A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin, levofloxacin, ethionamide, terizidone, Para-Aminosalicylate Sodium (PAS), pyrazinamide and pyridoxine. After 4 months of treatment, the patient developed a lump in the right br...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480805/ https://www.ncbi.nlm.nih.gov/pubmed/23112434 http://dx.doi.org/10.4103/0253-7613.100408 |
_version_ | 1782247628143067136 |
---|---|
author | Sharma, Parveen K. Bansal, Rekha |
author_facet | Sharma, Parveen K. Bansal, Rekha |
author_sort | Sharma, Parveen K. |
collection | PubMed |
description | A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin, levofloxacin, ethionamide, terizidone, Para-Aminosalicylate Sodium (PAS), pyrazinamide and pyridoxine. After 4 months of treatment, the patient developed a lump in the right breast which was approximately around 3 × 3 cm in size, tender on palpation, and not fixed to the underlying tissues. Ultrasonography (USG) revealed a hypoechoic mass of size 2.5 × 0.92 × 2.6 cm in the right breast region behind the nipple without any infiltration to the deeper structures. Gynecomastia due to ethionamide was suspected and the patient was advised anti-inflammatory drugs for 5 days without any change in drug therapy. The pain subsided; however, the nodule remained. Treatment was continued without any change till the patient stopped using the drugs on his own and without doctor's consent. Within a week of stopping of treatment the nodule also disappeared. |
format | Online Article Text |
id | pubmed-3480805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-34808052012-10-30 Gynecomastia caused by ethionamide Sharma, Parveen K. Bansal, Rekha Indian J Pharmacol Drug Watch A 43 year old male patient, known case of multidrug resistant tuberculosis, was prescribed antitubercular drugs: kanamycin, levofloxacin, ethionamide, terizidone, Para-Aminosalicylate Sodium (PAS), pyrazinamide and pyridoxine. After 4 months of treatment, the patient developed a lump in the right breast which was approximately around 3 × 3 cm in size, tender on palpation, and not fixed to the underlying tissues. Ultrasonography (USG) revealed a hypoechoic mass of size 2.5 × 0.92 × 2.6 cm in the right breast region behind the nipple without any infiltration to the deeper structures. Gynecomastia due to ethionamide was suspected and the patient was advised anti-inflammatory drugs for 5 days without any change in drug therapy. The pain subsided; however, the nodule remained. Treatment was continued without any change till the patient stopped using the drugs on his own and without doctor's consent. Within a week of stopping of treatment the nodule also disappeared. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3480805/ /pubmed/23112434 http://dx.doi.org/10.4103/0253-7613.100408 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Drug Watch Sharma, Parveen K. Bansal, Rekha Gynecomastia caused by ethionamide |
title | Gynecomastia caused by ethionamide |
title_full | Gynecomastia caused by ethionamide |
title_fullStr | Gynecomastia caused by ethionamide |
title_full_unstemmed | Gynecomastia caused by ethionamide |
title_short | Gynecomastia caused by ethionamide |
title_sort | gynecomastia caused by ethionamide |
topic | Drug Watch |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480805/ https://www.ncbi.nlm.nih.gov/pubmed/23112434 http://dx.doi.org/10.4103/0253-7613.100408 |
work_keys_str_mv | AT sharmaparveenk gynecomastiacausedbyethionamide AT bansalrekha gynecomastiacausedbyethionamide |